StrokeViewer Perfusion vs ContaCT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by NICo-Lab B.V.
VS
by Viz.AI

AI Verdict

StrokeViewer Perfusion offers specialized, quantitative CT perfusion analysis for ischemic stroke, focusing on detailed tissue information and specific stroke metrics. ContaCT, while also providing AI-powered stroke detection (LVO, ICH), is a broader care coordination platform that streamlines workflows and facilitates communication across multiple disease states, including PE and aneurysms. Therefore, StrokeViewer is ideal for deep imaging analysis within stroke, while ContaCT excels in comprehensive care team coordination and broader disease detection.

Choose StrokeViewer Perfusion if…

Choose StrokeViewer Perfusion if your primary need is detailed, quantitative analysis of CT perfusion scans to precisely characterize ischemic stroke. This tool excels at providing specific metrics like core and penumbra volumes, TMax, CBF, and CBV maps, which are crucial for guiding advanced treatment decisions based on tissue viability. It's ideal for centers requiring in-depth imaging insights for complex stroke cases.

View StrokeViewer Perfusion →

Choose ContaCT if…

Choose ContaCT if your organization prioritizes accelerating disease detection and streamlining the entire care coordination workflow for various time-sensitive conditions, including stroke. This platform is best suited for enabling rapid, AI-powered alerts to specialists, facilitating secure mobile communication, and integrating seamlessly with existing hospital IT infrastructure to optimize response times and improve patient outcomes across the care continuum.

View ContaCT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature StrokeViewer Perfusion ContaCT
Pricing Contact for pricing Subscription-based
Deployment Cloud-based; can be installed as a Docker container on standard computers or virtual platforms. Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR).
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ContaCT

Tool B offers a comprehensive mobile application for specialists to view images, communicate securely, and receive real-time alerts, along with integration with PACS and EHR systems. This provides a more integrated and interactive user experience compared to Tool A's focus primarily on mobile notifications and Docker deployment flexibility.

Clinical Value

ContaCT

While Tool A provides highly specialized and quantitative CT perfusion analysis crucial for stroke treatment, Tool B offers a broader AI-powered care coordination platform with detection capabilities for multiple critical conditions (LVO, ICH, HCM, PE, Aneurysm). Its focus on streamlining clinical workflows and providing guideline-based recommendations across various diseases offers a more extensive clinical impact beyond just imaging analysis.

Pricing & Value

Tie

Both tools lack transparent pricing details, making a direct comparison of their value propositions impossible. Tool A states 'Contact for pricing,' and Tool B indicates 'Subscription-based' with pricing varying significantly based on organization size and features, but neither provides specific cost information.

Enterprise Readiness

ContaCT

Both tools are HIPAA compliant, have BAA, and FDA clearance. However, Tool B explicitly mentions integration with existing hospital IT infrastructure (PACS, EHR) and has a significantly larger global deployment footprint, serving over 1,700 hospitals, demonstrating a higher level of proven scalability and adoption in complex enterprise environments.

Innovation

ContaCT

Tool A is innovative in its deep, quantitative CT perfusion analysis for stroke. However, Tool B positions itself as a 'pioneering AI-powered care coordination platform' with multi-disease detection capabilities, automated chart summarization, and guideline-based recommendations, representing a broader and more transformative application of AI for overall clinical workflow improvement.

Support & Docs

Tie

Both companies appear to offer dedicated support channels. NICo-Lab's website mentions '24/7 support' and a 'dedicated support team'. Viz.ai provides a 'Help Center' and offers 24/7 urgent phone support, along with various customer resources and user guides. Without more specific details on the depth of documentation or training resources, it is difficult to definitively declare a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature StrokeViewer Perfusion ContaCT
Product Name StrokeViewer Perfusion ContaCT
Company NICo-Lab B.V. Viz.AI
Tagline AI-powered stroke workflow technology for rapid diagnosis and treatment decisions. The leading AI care coordination platform for disease detection and workflow optimization.
Key Features (Stroke-related) AI-powered CT Perfusion analysis, Quantitative perfusion maps (TMax, CBF, CBV), Lesion map for core and penumbra volume quantification, Large Vessel Occlusion (LVO) detection, Hemorrhage detection and quantification, Collateral circulation assessment, ASPECTS scoring, Mobile notifications for critical findings AI-powered disease detection (LVO, ICH), Real-time AI-powered alerts and notifications, Mobile application for specialists to view images and communicate, Secure, HIPAA-compliant group communication messaging, Integration with PACS and EHR systems, High-fidelity 3D web and mobile image viewer

Videos

Demos, reviews, and walkthroughs featuring StrokeViewer Perfusion and ContaCT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

StrokeViewer Perfusion by NICo-Lab B.V. is an AI-powered image processing software that analyzes CT perfusion scans to provide quantitative brain tissue information for suspected ischemic stroke patients, aiding in rapid diagnosis and treatment decisions. Viz.ai's ContaCT is an AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows, with its initial application being for stroke.
StrokeViewer Perfusion focuses on CT perfusion analysis for ischemic stroke, offering features like LVO detection, hemorrhage detection, and ASPECTS scoring. ContaCT by Viz.ai provides broader AI-powered disease detection, including LVO, ICH, HCM, PE, and Aneurysm detection.
StrokeViewer Perfusion provides mobile notifications for critical findings related to its perfusion analysis. ContaCT by Viz.ai offers a comprehensive care coordination platform with real-time AI-powered alerts, a mobile application for specialists to view images and communicate, and secure, HIPAA-compliant group messaging.
StrokeViewer Perfusion provides quantitative perfusion maps (TMax, CBF, CBV), lesion maps for core and penumbra volume quantification, and ASPECTS scoring. ContaCT by Viz.ai focuses on AI-powered disease detection alerts and offers a high-fidelity 3D web and mobile image viewer, along with automated chart summarization.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.